Lupin recalls over 6 lakh bottles of hypertension drug in US: USFDA

Lupin Pharmaceuticals is recalling over 600,000 bottles of Ramipril blood pressure medication in the US due to an unapproved ingredient supplier. Dr. Reddy's Laboratories is also recalling 3,416 bottles of ibuprofen tablets due to failed specifications. Both recalls are voluntary, with Lupin's classified as Class II (temporary or reversible health consequences) and Dr.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/j8Opfxh
via IFTTT